JT
VERA icon

Jupiter Topco’s Vera Therapeutics VERA Stock Holding History

Jupiter Topco’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$758K Buy
+17,658
New +$658K ﹤0.01% 1913

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Jupiter Topco's VERA Position: Q2 2026 in Review

Jupiter Topco opened a new position in Vera Therapeutics (VERA) in Q2 2026: 17,658 shares worth $758K. The stake represents ﹤0.01% of the portfolio and ranks #1913 among its holdings.

202 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Jupiter Topco held 17,658 shares of Vera Therapeutics worth $758K as of Q2 2026.
  • Vera Therapeutics was a new Jupiter Topco position in Q2 2026.
  • Vera Therapeutics made up ﹤0.01% of Jupiter Topco's portfolio in Q2 2026, its #1913 holding.
  • 202 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.